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This study investigates the inhibitory effects of Korean mistletoe extract (KME) on adipogenic factors in 3T3-L1 cells and obesity
and nonalcoholic fatty liver disease (NAFLD) in mice fed a high-fat diet. Male C57Bl/6 mice fed a high-fat diet were treated with
KME (3g/kg/day) for 15 weeks for the antiobesity and NAFLD experiments. Body weight and daily food intake were measured
regularly during the experimental period. The epididymal pad was measured and liver histology was observed. The effects of KME
onthermogenesisandendurancecapacityweremeasured.TheeffectsofKMEonadipogenicfactorswereexaminedin3T3-L1cells.
Body and epididymal fat pad weights were reduced in KME-treated mice, and histological examination showed an amelioration of
fattyliverinKME-treatedmice,withoutaneffectonfoodconsumption.KMEpotentlyinducesmitochondrialactivitybyactivating
thermogenesis and improving endurance capacity. KME also inhibited adipogenic factors in vitro. These results demonstrate the
inhibitoryeffectsofKMEonobesityandNAFLDinmicefedahigh-fatdiet.Theeffectsappeartobemediatedthroughanenhanced
mitochondrial activity. Therefore, KME may be an effective therapeutic candidate for treating obesity and fatty liver caused by a
high-fat diet.
1. Introduction
Obesity is the most common metabolic disorder and results
from the combined effects of excess energy intake and
reduced energy expenditure [1]. It is one of the fastest
growing major disorders throughout the developed nations
[2]. It is associated with a variety of clinical disorders in
developed nations [2]. Obesity is associated with a variety of
clinical disorders, including hypertension, insulin resistance,
glucoseintolerance,anddyslipidemia.Itiswellknownthatan
oversupplyoffatisassociatedwiththedevelopmentofobesity
inmice[3].Long-termfeedingwithahigh-fatdietcaninduce
obesity with hyperlipidemia, insulin resistance, hyperphagia,
and hypergluconemia [4, 5].
Nonalcoholic fatty liver disease (NAFLD) is present in
up to one-third of the general population and affects all ages
and ethnic groups. NAFLD is the second leading cause of
death in the general population [6, 7]. At present, there is
no pharmacological agent known to reverse NAFLD and
effective medical interventions have focused on the modi-
fication of risk factors, such as weight reduction and diet
[8].
Mistletoe is a hemiparasitic plant growing all over the
world on various deciduous trees, such as oak. It has been2 Evidence-Based Complementary and Alternative Medicine
used as a traditional herbal medicine, especially in Europe
[9]. Korean mistletoe (KM, Viscum album cololatum) extract
(KME) has been shown to have anticancer [10], antioxi-
dant [11], antidiabetes [12] and antidementia [13]e ff e c t s ,
and it enhances immune system function [14]. Recently,
we reported that KME significantly increases mitochondrial
function [15].
Mitochondria are known as “cellular power plants”
becausetheygeneratemostofthecellularsupplyofadenosine
triphosphate (ATP) which is used as a source of chemical
energy. Studies have implicated mitochondria in several
human diseases, including metabolic diseases [16], cardiac
dysfunction [17], mental disorders [18], and the aging pro-
cess [19]. Decreased mitochondrial respiration rates [20]
and reduced expression of genes involved in mitochondrial
oxidative capacity [21] have been reported in diet-induced
obese rats. Because KME improves mitochondrial function,
we asked whether it has beneficial effects on obesity.
It is well known that adipocyte differentiation and the
extent of subsequent fat accumulation are closely related to
the occurrence and advancement of various diseases, such as
coronary artery disease and obesity [1, 22, 23]. 3T3-L1 cells
haveservedasausefulinvitromodelforadipocytedifferenti-
ation and function [24]. The differentiation of preadipocytes
into adipocytes requires a variety of effectors that activate a
cascade of transcription factors, such as CCAAT/enhancer-
binding protein-𝗼 (C/EBP-𝗼), peroxisome proliferator-
activated receptor𝗾 (PPAR-𝗾), and sterol regulatory element
binding element protein-1c (SREBP-1c). This cascade begins
with the CCAAT enhancer-binding protein- (C/EBP-)
𝗽 and 𝗿, which induces the expression of C/EBP-𝗼 and
PPAR-𝗾 [25–27]. These transcription factors coordinate the
expression of genes involved in creating and maintaining
the adipocyte phenotype, including genes for adipocyte
fatty acid-binding protein, glucose transporter 4, lipoprotein
lipase (LPL) and leptin [28, 29]. SREBP-1c is strongly
associated with SREBP cleavage-activating protein (SCAP).
Activated SREBP-1c accelerates adipogenesis through the
overexpression of adipogenic enzymes, such as fatty acid
synthase(FAS), acyl-CoA synthase (ACC), and acyl-CoA
carboxylase (ACS). LPL is the major enzyme that hydrolyzes
triglyceride (TG) molecules of chylomicrons and VLDL
particles. The released free fatty acids are either oxidized to
g e n e r a t eA T Pi nm u s c l eo rs t o r e di na d i p o s et i s s u e[ 30].
We measured the inhibitory effect of KME on adipogenic
f a c t o r si n3 T 3 - L 1c e l l sa n do nt h ed e v e l o p m e n to fo b e s i t y
and NAFLD in mice fed a high-fat diet. Our data show that
KME suppresses adipocyte differentiation through down-
regulation of adipogenic factors and could ameliorate obesity
and NAFLD in mice fed a high-fat diet. Our results indicate
the great potential of KME as a potential metabolic regulator
of adipocyte differentiation and a potential therapeutic agent
f o rp r e v e n t i n go rt r e a t i n go b e s i t ya n dN A F L D .
2. Materials and Methods
2.1. Preparation of KME. Mistletoe growing on oak was
harvestedfromGangwon-do,RepublicofKorea,inFebruary.
The mistletoe was 1 or 2 years old, and the leaves, stems,
a n df r u i t sw e r ec u ti n t o2j o i n t sf r o mt h ee n do fab r a n c h ,
washed with distilled water (DW), and dried. The vacuum-
packed mistletoe was stored at −80
∘C until extracted. Then
mistletoe leaves, fruits, and stems were freeze-dried, crushed
a n dg r o u n di na p p r o x i m a t e l y1 0v o l u m e so fD Wf o r3 0
seconds. After being washed, they were ground in a mixer
for 2 minutes and stirred for 16 hours at 4
∘C. To obtain fine
mistletoeextract,thehomogenizedmistletoewascentrifuged
at 8,000rpm for 30 minutes at 4
∘C, and the resulting super-
natant was successively filtered through different pore sizes
(0.9and0.45𝜇m).Themistletoeextractwasfreeze-driedand
resuspended in DW at an appropriate dilution factor.
2.2. Animals and Diets. Lean, male C57BL/6 mice (7 weeks
old) were purchased from Central Lab Animal Inc. (Seoul,
Republic of Korea). All mice were housed for 1 week under
a1 2 / 1 2 - h o u rl i g h t / d a r kc y c l ei nat e m p e r a t u r e — ( 22 ± 1
∘C)
and humidity—(55 ± 5%) controlled room and fed standard
laboratory chow and water ad libitum. KME was mixed with
either powdered chow (M07, Feedlab, Republic of Korea) or
high-fat (D12327, Research Diets, Inc., New Brunswick, NJ,
USA) feed at a concentration of 4g/kg of food to provide a
3000mg/kg/day (mpk) dose. The powdered chow was then
made into pellets. Control groups received pellets with-
out KME. These dietary amounts represent the maximum
amount of chow that these animals were able to consume
during a 24-hour period. Seven C57BL/6 mice on the above
ad libitum diets had their daily average caloric intake and
weekly body weight measurement during the course of the
study. At the conclusion of the in vivo experiment, the mice
were sacrificed and the epididymal pads were collected and
weighed.
2.3. Cold Test. The adaptive thermogenic response was mea-
s u r e di nac o l dt e s t ,d u r i n gw h i c ht h ea n i m a l sw e r ei n d i v i d u -
ally housed at 4
∘Cf o r6h o u r s[ 31].
2.4. Liver Histology. Liver tissues were isolated immediately
after sacrifice. For hematoxylin and eosin (HE) staining, tis-
sueswerefixedin10%formalinandprocessedandembedded
in paraffin prior to sectioning (10𝜇m.) and staining. Liver
biopsies for electron microscopy were cut into 1mm pieces,
fixed immediately after collection in Karnovsky fixative
(glutaraldehyde in cacodylate buffer), and kept at 4
∘C. The
secondstepinvolvedpostfixationwith1%osmiumtetraoxide
in 0.1M cacodylate buffer for 1 hour at 4
∘C. Tissues were
then dehydrated through successive baths of graded alcohol,
followed by a propylene oxide bath and a treatment with
propylene oxide and resin mix before being embedded in a
pure epoxy resin (araldite, Epon 812) that solidified after 48h
at60
∘C.Semithinsectionswerecutat2𝜇m,stainedwithtolu-
idine blue, and then analyzed by light microscopy. Ultrathin
sections were cut at 70nm and examined with an electron
microscope (BX 50, Olympus, Japan). Electron micrographs
(400xmagnification)weredigitizedandanalyzedusingACD
SEE, version 4.0. The liver of 1 mouse from each group
(control, high-fat diet (HFD), HFD + KME 3000mg/kg)Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Effect of KME on body weight and food intake in mice fed a high-fat diet for 15 weeks. (a) Changes in body weight gain at each
treatment period are shown. (I) C: chow diet; (∙) C + KME: chow diet plus KME 3000mg/kg; (△) HFD: high-fat diet; (򳵳) HFD + KME:
high-fat diet plus KME 3000mg/kg. (b) Average food intake expressed as kcal/mouse/day. (c) Epididymal fat weight expressed as percentage
of total body weight. Values represent mean ± standard error of mean (SEM;
∗𝑃 < 0.05, 𝑛=7per group).
was measured. In brief, the following criteria were used
for scoring hepatic steatosis: grade 0, grade 1, hepatocytes
occupying <33% of the hepatic parenchyma; grade 2, fatty
hepatocytes occupying 33–66% of the hepatic parenchyma;
andgrade3,fattyhepatocytesoccupying>66%ofthehepatic
parenchyma.
2.5. Endurance Test. M i c ew e r es u b j e c t e dt oa ne n d u r a n c e
test using a variable-speed belt treadmill enclosed in a plex-
iglass chamber with a stimulus device consisting of a shock
grid attached to the rear of the belt (Columbus Instruments
Oxymax System, Columbus, OH, USA). The shock grid was
s e tt od e l i v e r0 . 2m A ,w h i c hc a u s e da nu n c o m f o r t a b l es h o c k
but did not physically harm or injure the animals. Animals
were acclimatized to the test using a habituation protocol.
Mice were run at 16.2 meter/minutes for 10 minutes with
a5
∘ incline. For high-fat- (HF-) fed animals, the experiment
was initiated at 10.8 meter/minutes at a 0
∘ incline. The speed
was gradually increased from 10.8 to 24.6 meter/minutes
and then maintained until exhaustion [15]. Exhaustion was
determined to have been reached if the mice were unable to
run for 10 seconds [32], at which point the electric shock was
discontinued. Figure 1 shows the running test protocol.
2 . 6 .C e l lC u l t u r ea n dI n d u c t i o no fA d i p o c y t eD i ff e r e n t i a t i o n .
3T3-L1 preadipocytes purchased from ATCC (American
Type Culture Collection, Manassas, VA, USA) were cultured
in Dulbecco’s-modified Eagle’s medium (DMEM, Hyclone,
Logan, UT, USA) containing 10% bovine calf serum (BCS,
Hyclone, Logan, Utah, USA) at 37
∘C in a humidified atmo-
sphereof5%CO2.After3or4days,thecellshadreached90%
confluence and were collected with 0.05% trypsin/0.53mM4 Evidence-Based Complementary and Alternative Medicine
Table 1
Gene name Accession number Sequence
ACC AY451393 Forward 5
򸀠-GAG TGA CTG CCG AAA CAT CTC TG-3
򸀠
Reverse 5
򸀠-GCC TCT TCC TGA CAA ACG AGT-3
򸀠
ACS NM 007981 Forward 5
򸀠-TGA CCT CTC CAT GCA GTC AG-3
򸀠
Reverse 5
򸀠-GAG CCT ATG CAC TCA GCC AGT-3
򸀠
FAS NM 007988 Forward 5
򸀠-TGG GTT CTA GCC AGC AGA GT-3
򸀠
Reverse 5
򸀠-TAC CAC CAG AGA CCG TTA TGC-3
򸀠
LPL BC003305 Forward 5
򸀠-GCC CAG CAA CAT TAT CCA GT-3
򸀠
Reverse 5
򸀠-GGTCAG ACT TCC TGC TAC GC-3
򸀠
SREBP-1c 8C056922 Forward 5
򸀠-AAT GGT CCA GGC AAG TTC TGG GT-3
򸀠
Reverse 5
򸀠-TCC CTC TCA GCT GTG GTG GTG AA-3
򸀠
C/EBP-𝗼 M62362 Forward 5
򸀠-TGC TGG AGT TGA CCA GTG AC-3
򸀠
Reverse 5
򸀠-AAA CCA TCC TCT GGG TCT CC-3
򸀠
PPAR-𝗾 NM 011146 Forward 5
򸀠-TTT TCA AGG GTG CCA GTT TCA ATC C-3
򸀠
Reverse 5
򸀠-AAT CCT TGG CCC TCT GAG AT-3
򸀠
UCP1 NM 009463 Forward 5
򸀠-GGC CCT TGT AAA CAA CAA AAT AC-3
򸀠
Reverse 5
򸀠-GGC AAC AAG AGC TGA CAG TAA AT-3
򸀠
𝗽-Actin NM 007393 Forward 5
򸀠-GAC TAC CTC ATG AAG ATC-3
򸀠
Reverse 5
򸀠-GAT CCA CAT CTG CTG GAA-3
򸀠
ACD: acyl-coenzyme A dehydrogenase; ACO: acyl-coenzyme A oxidase; ACS: acetyl-coenzyme A synthetase; COX-2: cyclooxygenase 2; CPT-1: carnitine
palmitoyltransferase 1; FAS: fatty acid synthase; HSL: hormone-sensitive lipase; IL-6: interleukin-6; LPL: lipoprotein lipase; MCP1: monocyte chemotactic
protein 1; SREBP-1c: sterol regulatory element binding protein-1.
EDTAtreatment.Aftercentrifugation(1300rpm,5minutes),
the cells were plated in 6-well plates at a concentration
of 3×1 0
4 cell/well. One day after confluence (designated
“day 0”), cell differentiation was induced with a mix-
ture of methylisobutylxanthine (0.5mM), dexamethasone
(0.25mM), and insulin (5mg/mL) in DMEM containing
10% fetal bovine serum (FBS). On day 2 and thereafter,
DMEM supplemented with 10% FBS and 5mg/mL insulin
wasreplacedevery2days.3T3-L1adipocytes,7to8daysafter
differentiation,weretreatedwithKME6𝜇g/𝜇Lorphosphate-
buffered saline (PBS) for 24 hours.
2.7. RNA Preparation and Real-Time RT-PCR. Total RNA
was isolated from 3T3-L1 adipocytes using TRIzol reagent
(Invitrogen, Carlsbad, CA, USA). Cells were homogenized
by 4-5 passages through a 23-gauge needle. After a 5-minute
reaction, samples were mixed with chloroform by vortex
machine for 15 seconds. Samples were then centrifuged at
12,000rpm for 10 minutes at 4
∘C. The colorless supernatant
was transferred into new tubes. Total RNA was precipi-
tated by mixing with isopropyl alcohol and centrifuging at
12,000rpm. The resulting RNA pellets were washed with
75% ethanol and dissolved in RNase-free water. RNA was
quantified by spectrophotometry at A260 a n dt h e ns t o r e d
at −80
∘C. Total extracted RNA (1𝜇g) mixed with annealing
oligo dT primer and RNase-free water was incubated in
a thermocycler for denaturing RNA. Reactant was mixed
with 5X first strand buffer, 20mM DTT, 10mM dNTP mix,
RNase-free water, and Superscript II reverse transcriptase.
The mixtures were incubated in a thermocycler (42
∘Cf o r
1h o u ra n d7 2
∘C for 7 minutes) to generate cDNA. Real-
time RT-PCR analysis was performed with an AB 7500
real-time PCR system (Applied Biosystems, Foster City, CA,
USA). Samples containing 2X SYBR Green PCR Master Mix
(Applied Biosystems, Foster City, CA, USA), 0.5 𝜇mol each
of appropriate primers, and cDNA were incubated in the AB
7500real-timePCRsystemforaninitialdenaturationat94
∘C
for10minutes,followedby40PCRcycles.Eachcyclewasrun
at 95
∘C for 15 seconds and at 60
∘Cf o r1m i n u t e .Th eo l i g o n u -
cleotide primers for the experiment are listed in Table 1.
𝗽- a c t i nw a su s e da sa ni n t e r n a lh o u s e k e e p i n gc o n t r o l .T o
confirm amplification of specific transcripts, melting curve
profiles were produced at the end of each PCR cycle by
cooling the sample to 65
∘C for 15 seconds and heating slowly
to 95
∘C, with continuous fluorescence measurement.
2.8. Statistical Analysis. Data (means ± SE) were analyzed
using GraphPad Prism (version 5.04, GraphPad Software,
USA). Unpaired two-tailed Student’s t-tests were used to
evaluate differences between means, as indicated. 𝑃 values <
0.05 were considered statistically significant.
3. Results
3.1. KME-Induced Body Weight, Dietary Intake, and Adiposity
Changes in HFD-Fed Mice. During the 15-week experiment,
body weight and food intake were measured weekly. As
shown in Figure 1,t h eK M E - t r e a t e dg r o u ph a das l i g h t
decrease in body weight compared to the control group.
However, this effect was significantly pronounced in animals
t h a tw e r ef e da nH Fd i e tw i t hK M E .Th ed i ff e r e n c eb e t w e e n
the KME-treated and control animals became significant at
week9.Attheendoftheexperiment,thebodyweightofmice
fed KME was 20% lower (𝑃 < 0.05) than that of the controlEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: effect of KME on body temperature during the cold test (4
∘C for 6h) and on UCP1 mRNA expression in BAT. (a) Hourly changes
in body temperature are shown. (△) HFD: high-fat diet; (򳵳) HFD + KME: high-fat diet plus KME 3000mg/kg (
∗𝑃 < 0.05, 𝑛=7per group).
(b) The relative UCP1 mRNA expression level in BAT of animals treated with HFD or HFD + KME (high-fat diet plus KME 3000mg/kg) as
quantified by real-time PCR. Values represent mean ± SEM (
∗𝑃 < 0.05, 𝑛=3 ).
g r o u p ,w h e r e a sH Fd i e tp l u sK M Em i c ew e i g h e da l m o s tt h e
same as the mice that ate normal chow (Figure 1(a)). These
effects of KME on body weight were not due to decreased
food intake, as the amount of kcal consumed per mouse
overa24-hourperiodremainedunchanged(Figure 1(b)).The
dataindicatethatKMEmighthaveantiobesityeffectsin vivo,
without affecting food intake.
Totestwhetherbodyweightlosswascausedbydecreased
adiposity, animals were sacrificed and epididymal white
adipose tissue was dissected and weighed. This analysis
revealed that epididymal white adipose tissue was signifi-
cantly reduced in the HF diet plus KME group (Figure 1(c)).
3.2. Effect of KME on Cold Exposure in HFD-Fed Mice. We
performed a cold test to assess the effect of KME on adap-
tive thermogenesis capacity. KME-treated animals main-
tained higher body temperatures than nontreated animals
(Figure 2(a)), suggesting that it improved this capacity. To
test whether thermogenesis is accompanied by changes in
the expression of genes involved in thermogenesis, total
RNA was prepared from BAT. We examined mRNA lev-
els of UCP1, the major contributor to heat production,
by Real-time RT-PCR. Figure 2(b) shows that the mRNA
level of UCP1 was remarkably increased in KME-treated
mice.
3.3. Effect of KME on Endurance Capacity of HFD-Fed
Mice. B e c a u s eK M Er e d u c e db o d yw e i g h t( Figure 1(a))a n d
increasedthermogenesis(Figure 3),weevaluatedtheeffectof
KME administrationon a treadmill endurancetest. The mice
were trained to run at 16.2 meter/minutes for 10 minutes at
a5
∘ incline the day before the running test, according to the
procedure used for our previous report [15]. The experiment
wasinitiatedat10meter/minutesata0
∘ inclinewithagradual
increase in speed. The mice were run until exhaustion, which
was defined as remaining on the shock grid for longer than
10 consecutive seconds. Surprisingly, KME-treated mice ran
twice as far as high-fat diet mice (Figure 3).
3.4. Effect of KME on Hepatic Histology of HFD-Fed C57BL/6.
One of the most common characteristics among people with
obesityisthedevelopmentoffattyliver[33,34].Therefore,we
also analyzed the effect of KME on fatty liver development.
Histologic evaluation is regarded as the “gold standard” for
assessing the presence and severity of NAFLD [35]. We
histologicallyevaluatedliversectionstodeterminetheextent
to which KME attenuated hepatic steatosis development. As
showninFigure 4,thecontrolgroupexhibitedlittlehistologic
evidence of hepatic steatosis. Severe steatosis was observed
in mice fed a high-fat diet without KME. However, a marked
r e d u c t i o ni nt h ed e g r e eo fs t e a t o s i sw a ss e e ni nl i v e r sf r o m
high-fat diet mice treated with KME. Furthermore, hepatic
steatosis scores were dramatically lower in the high-fat diet
mice fed KME (grade 1).
3 . 5 .E ff e c to fK M Eo nm R N AL e v e l so fA d i p o g e n i cF a c t o r s
in 3T3-L1 Adipocytes. To demonstrate the inhibitory mech-
anism of KME on adipocyte differentiation,we measured the
expressionlevelsofthetranscriptionfactorsPPAR-𝗾,C/EBP -
𝗼, and SREBP-1c in 3T3-L1 cells treated with 6𝜇g/𝜇Lo f
KME. Our results show that PPAR-𝗾,C / E B P - 𝗼,a n dS R E B P -
1c mRNA levels were decreased by 64%, 60%, and 32%,
respectively, (Figure 5(a)). We also measured the mRNA
expression levels of adipogenic enzymes, such as FAS, ACS,
andA CC.W efoundthattheywerereducedby69%,55%,and
22%,respectively(Figure 5(b)).LPLexpressionisnotdirectly6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Endurance capacity was enhanced in KME-treated mice over 15 weeks. Average times (a) and distance (b) run until exhaustion are
presented for animals treated with HF or HF + KME at 3000mpk. Values represent the mean ± SEM (
∗𝑃 < 0.05, 𝑛=7per group).
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Figure4:Histologicevaluationofhepaticsteatosis.Hematoxylinandeosinstainingofliverfrommicefedchowdiet(c),high-fatdiet(HFD),
or high-fat diet supplemented with KME at 3000mpk (HFD + KME) (original magnification 400x). High-fat diet mice had severe hepatic
steatosis. High-fat diet-induced mice fed KME at 3000mpk had significantly reduced evidence of hepatic steatosis.
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Figure 5: mRNA expressions of adipogenic enzymes and transcription factors in KME-treated 3T3-L1 adipocytes. On day 8 after
differentiation, adipocytes were cultured in 6-well plates with or without KME (6𝜇g/𝜇L) for 18 hours. Graphs represent mRNA expression
of (a) adipogenic enzymes ACC, ACS, FAS, and LPL and (b) adipogenic transcription factors SREBP-1c, C/EBP-𝗼,a n dP P A R - 𝗾.D a t aa r e
expressed relative to untreated control cells and represent the mean ± SEM (
∗𝑃 < 0.05,
#𝑃 < 0.01,
∗∗𝑃 < 0.005,
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associated with lipid synthesis but is strongly associated with
adipogenesis. Therefore, we measured the expression level of
LPL mRNA and found that the level of expression in KME-
treated 3T3-L1 cells was decreased by 89% compared to that
of untreated cells (Figure 5(a)).
4. Discussion
Our study is the first to demonstrate that KME prevents
weight gain in mice. We examined the effects of KME on
HFD-induced obesity in C57Bl/6 mice. Our results showed
that body weight gain in groups fed a diet supplemented
with KME was reduced compared to control HFD mice.
This effect was more distinct in animals fed a high-fat diet.
Epididymal WAT in C57Bl/6 mice was significantly reduced
by KME supplementation. This study also provides evidence
thatdietarysupplementationofKMEprotectsagainsthepatic
steatosis development. We have considered the possibility
that the effect of KME may be mediated by food intake
because decreased food intake would be expected to signif-
icantly affect body weight, which influences hepatic steatosis.
In this study, however, food intake did not differ between
the groups. This suggests that KME directly protected
against obesity and hepatic steatosis independent of food
intake.
Brown adipose tissues (BATs) use stored triacylglycerols
(TG) to maintain body temperature. These cells produce
energy from fatty acid metabolism to generate heat through
the action of uncoupling protein 1 (UCP1), a mitochon-
d r i a lp r o t e i nf o u n do n l yi nb r o w na d i p o s et i s s u e .B r o w n
adipocytes contain less TG and more mitochondria than
white adipocytes, resulting in their unique color. KME
treatment increased UCP1 expression levels in BAT, which
poised the mitochondria for respiration uncoupling [36].
This effect is consistent with the observed enhancement
of cold tolerance and helps explain the increase in energy
expenditure and resistance to weight gain.
Mitochondrialfunctioncanaffecttotalbodymetabolism.
This is most evident in muscle, a metabolically flexible
tissue that switches between lipid and carbohydrate sub-
s t r a t e st of u l fi l le n e r g yr e q u i r e m e n t s[ 37]. One study found
that mitochondrial OXPHOS activity within the oxidative
soleus muscle, which is resistant to fatigue and is dependent
on mitochondrial activity for ATP production, was more
affected than in the glycolytic muscle tibialis anterior.Th e
main changes included a reduction in respiratory chain
activity with a concomitant decrease in mitochondrial ATP
production [38]. In line with this finding and previously
[15], KME significantly improved muscle oxidative capacity,
resulting in enhancing the endurance.
To further consolidate our hypothesis that KME inhibits
obesity, we evaluated the effects of KME treatment in
vitro using an adipocyte differentiation development system,
which is regulated by transcriptional activators such as
PPAR-𝗾,C/EB P -𝗼, andsometranscriptionalregulatorsat the
molecular level [39, 40]. PPAR-𝗾 is a member of the nuclear
receptor superfamily of transcription factors and is domi-
nantlyexpressedinadiposetissue.Thesetranscriptionfactors
appear to be the main activators of adipocyte differentiation
[41].
The C/EBPs belong to a large family of leucine zipper
transcription factors [42]. C/EBP-𝗼 is a promising candidate
transcription factor for directly controlling adipocyte differ-
entiation [43].
SREBP1 is known to critically cross-activate a ligand
binding domain of PPAR-𝗾 and activate the production of an
endogenous PPAR-𝗾 ligand [27]. SREBP1 also regulates the
expressionofenzymesinvolvedinfattyaciddesaturationand
lipogenesis.
Adipocyte differentiation involves a series of pro-
grammed changes in the expression of specific genes. Adipo-
genesis can be induced through the action of some enzymes,
such as FAS, ACC, and acyl-CoA synthetase (ACS). The
expressions of these genes are regulated by transcription
factors, including PPAR-𝗾,C / E B P - 𝗼,a n dS R E B P 1 ,w h i c h
are known to be crucial activators for adipogenesis and
showed early changes in gene expression during adipocyte
differentiation [44, 45]. In this study, we showed that KME
treatment significantly decreased SREBP-1c, C/EBP-𝗼,a n d
PPAR-𝗾 mRNA expression in cultured 3T3-L1 adipocytes
and inhibited expression of adipocyte-specific proteins (FAS,
ACC, ACS, and LPL). Collectively, these observations sug-
gest that KME suppresses adipocyte differentiation by reg-
ulating the expression levels of adipogenic transcription
factors.
Furtherinvestigationisnecessarytodefinespecificmech-
anisms by which KME protects against obesity-mediated
hepaticsteatosis.Toelucidatethemechanismassociatedwith
the antiobesity effects of KME, additional studies should
be conducted with the most abundant component in KME.
Sung [46] reported that pentacyclic triterpenoid oleanolic
acid has antiobesity activity. We have shown that KME
contains oleanolic acid, which has anticancer activity [47]. It
ispossiblethatoleanolicacidmightbetheleadingantiobesity
component in KME.
5. Conclusion
KME had marked inhibitory effects on the development of
obesity and NAFLD in mice fed high-fat diets. Activating
endurance capacity and increasing thermogenesis are two
possible mechanisms for the antiobesity effect of KME. This
findingsuggeststhatKMEmaybeapotentialdietarystrategy
for preventing obesity and NAFLD.
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